doi:10.1016/0016-5085(89)90081-4
Used for liver support, neurological health, skin brightening, heavy metal detox, and as adjunctive therapy in chronic illness management
Red flags requiring immediate evaluation include severe abdominal pain (possible pancreatitis), persistent vomiting leading to dehydration, suicidal thoughts, development of new eating disorder behaviors, syncope, chest pain, hematemesis/melena, severe constipation/obstipation, orthostatic hypotension, or marked electrolyte abnormalities
Puede aprender a minimizar los efectos del tratamiento relacionados con la dieta siguiendo estas directrices bsicas: Comience una dieta baja en grasa unos das, o incluso una semana, antes de empezar a tomar las cpsulas
FDA-approved GHRH analogue (as Egrifta for HIV lipodystrophy)
However, clinical evidence supporting these claims is extremely limited, and BPC-157 is not approved for human use by any major regulatory authority